{"id":"W2460310329","doi":"10.4137/bcbcr.s39615","title":"Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Basic and Clinical Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Eribulin; Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Taxane; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001371307,0.0003308659,0.001892428,0.0002491538,0.00009485738,0.00003185485,0.0002892118,0.0001011648,0.004491785],"category_scores_gemma":[0.0003610351,0.0001648928,0.000091093,0.0009233138,0.0007321327,0.0002350909,0.0002271607,0.0004141386,0.000007490002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003342234,"about_ca_system_score_gemma":0.0009388612,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0216314,"about_ca_topic_score_gemma":0.01607722,"domain_scores_codex":[0.9953778,0.001291659,0.001058685,0.0008804068,0.00078746,0.0006040347],"domain_scores_gemma":[0.9940029,0.004053252,0.0002932995,0.0004271941,0.0007811936,0.0004420974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6320924,0.01303833,0.1974724,0.00003775554,0.002180723,0.00009073941,0.000162498,0.000001469528,0.0002367856,0.000002778384,0.0001874508,0.1544967],"study_design_scores_gemma":[0.6878558,0.007701444,0.3018334,0.0005377902,0.001374432,0.000003872631,0.0002377766,0.0001011054,0.00007848752,0.00002054553,0.00007596081,0.0001793949],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911131,0.000996054,0.000008561862,0.001754244,0.0001747824,0.003947169,0.001899521,0.00001821794,0.00008833266],"genre_scores_gemma":[0.9934804,0.004213618,0.00009083778,0.00007967315,0.0001276927,0.001314823,0.00006625642,0.0000434169,0.0005832384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1543173,"threshold_uncertainty_score":0.9964182,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2671860688400545,"score_gpt":0.5786689249457595,"score_spread":0.311482856105705,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}